Clinical trial
STAAR-2 Clinical Study
NCT00368901 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00368901 |
|---|---|
| Title | STAAR-2 Clinical Study |
| Official title | A Multicenter Study Using Once Every Other Week Subcutaneous Administration of Aranesp™ (Darbepoetin Alfa) and Iron Guided Algorithms to Treat Subjects With Anemia of Chronic Renal Insufficiency (CRI) |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Kidney Disease, Chronic Renal Insufficiency, Kidney Disease, Pre-dialysis, Pre-ESRD |
| Intervention type | Drug |
| Interventions | Darbepoetin alfa |
| Enrollment | 618 |
| Start date | Jan 1, 2002 |
| Primary completion | Mar 1, 2004 |
| Completion | May 1, 2004 |
| First posted | Aug 29, 2006 |
| Last update posted | Mar 5, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: